Lexeo Therapeutics, Inc. · NASDAQ:LXEO

Townsend Richard Nolan sold 25,947 Lexeo Therapeutics, Inc. shares (Form 4)

Traded Jun 29 to Jul 1, 2026 · Filed Jul 1, 2026

From Jun 29 to Jul 1, 2026, Townsend Richard Nolan (Director, Chief Executive Officer) sold 25,947 Lexeo Therapeutics, Inc. shares at US$4.48 for US$116K, leaving 377,817 shares. Filed Jul 1, 2026 (Form 4).

Sold
25,947 shares
Price
US$4.48
Value
US$116K
Holding after
377,817 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 29, 2026Common StockAward67,000403,764Direct
Jul 1, 2026Common StockSale25,947US$4.48377,817Direct

Source

View original at SEC

Related